FDA NDC Directory · JSON-LD · Markdown

MONTELUKAST SODIUM

NDC 27241-017 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Generic nameMONTELUKAST
Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203328
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsMONTELUKAST SODIUM (5 mg/1)
Marketing started20150813
Package count2

External sources

Source: openFDA. Public-domain (CC0).